WELLS FARGO & COMPANY/MN - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 9 filers reported holding BONE BIOLOGICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2023$13
+30.0%
52
+10.6%
0.00%
Q4 2022$1047
+123.8%
0.00%
Q3 2022$0210.00%
Other shareholders
BONE BIOLOGICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,500,000$387,7500.34%
MFA WEALTH ADVISORS, LLC 96,774$25,0160.01%
Walleye Capital LLC 806,159$208,3920.00%
Warberg Asset Management LLC 30,000$7,7550.00%
WELLS FARGO & COMPANY/MN 52$130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 17,824$50.00%
UBS Group AG 43,653$11,3060.00%
Tower Research Capital LLC (TRC) 8,311$20.00%
View complete list of BONE BIOLOGICS CORP shareholders